Indications

Asthma (see Asthma, [[Asthma]])

• Indications
  • Peripheral Eosinophilia: ≥300 cells/uL
  • Sputum Eosinophilia: ≥3%
  • Symptoms Not Well-Controlled on Medium-High Dose Inhaled Corticosteroids and Long-Acting Beta Agonist (LABA)
• Clinical Efficacy
  • xxxx

---

Pharmacology

• Fully Human Monoclonal Antibody Which Binds to Alpha Subunit of Interleukin-4 (IL-4) Rceeptor

Metabolism

• xxxx

---

Administration

• xxxx

Dose Adjustment

• Hepatic:
• Renal:

---

Adverse Effects

Other Adverse Effects

• xxx
• xxx
• xxx

---

References

• xxxx